These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23536344)

  • 41. An immunohistochemical study of P53 and Ki-67 in gastrointestinal adenoma and adenocarcinoma using tissue microarray.
    Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y
    Anticancer Res; 2006; 26(3B):2353-60. PubMed ID: 16821616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
    Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
    Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of PIN1 in Gastrointestinal Stromal Tumours and its Clinical Significance.
    Jiang L; Cao M; Hu J; Chen J
    Anticancer Res; 2016 Mar; 36(3):1275-80. PubMed ID: 26977025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P53, KI-67, CD117 expression in gastrointestinal and pancreatic neuroendocrine tumours and evaluation of their correlation with clinicopathological and prognostic parameters.
    Kımıloğlu Şahan E; Erdoğan N; Ulusoy İ; Samet E; Akyıldız İğdem A; Gönüllü D
    Turk J Gastroenterol; 2015 Mar; 26(2):104-11. PubMed ID: 25835106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ki67 and p53 in gastrointestinal stromal tumors--GIST.
    Neves LR; Oshima CT; Artigiani-Neto R; Yanaguibashi G; Lourenço LG; Forones NM
    Arq Gastroenterol; 2009; 46(2):116-20. PubMed ID: 19578612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of high expression of Groβ with clinical and pathological characteristics of unfavorable prognosis in gastrointestinal stromal tumors.
    Zhao H; Zhu H; Jin Q; Zhang S; Wang W; Wang D; Huang J
    Dis Markers; 2015; 2015():171035. PubMed ID: 25944970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
    Stotz M; Liegl-Atzwanger B; Posch F; Mrsic E; Thalhammer M; Stojakovic T; Bezan A; Pichler M; Gerger A; Szkandera J
    PLoS One; 2016; 11(7):e0159448. PubMed ID: 27454486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic Factors in Patients with Primary Hemangiopericytomas of the Central Nervous System: A Series of 103 Cases at a Single Institution.
    Zhu H; Duran D; Hua L; Tang H; Chen H; Zhong P; Zheng K; Wang Y; Che X; Bao W; Wang Y; Xie Q; Gong Y
    World Neurosurg; 2016 Jun; 90():414-419. PubMed ID: 26960287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Factors of Prostate Cancer in Tunisian Men: Immunohistochemical Study.
    Missaoui N; Abdelkarim SB; Mokni M; Hmissa S
    Asian Pac J Cancer Prev; 2016; 17(5):2655. PubMed ID: 27268646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological behavior due to cell proliferation markers of gastrointestinal stromal tumors.
    Menéndez P; Padilla D; Cubo T; Villarejo P; Gambí D; Menéndez JM; Colina F; García M; Lora D; Martín J
    Hepatogastroenterology; 2011; 58(105):76-80. PubMed ID: 21510290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclooxygenase-2 expression and clinical outcome in gastrointestinal stromal tumors.
    Stewart AE; Heslin MH; Arch J; Jhala N; Ragland B; Gomez F; Bland KI; Arnoletti JP
    J Gastrointest Surg; 2006 Feb; 10(2):315-9. PubMed ID: 16455468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience.
    Lusby K; Savannah KB; Demicco EG; Zhang Y; Ghadimi MP; Young ED; Colombo C; Lam R; Dogan TE; Hornick JL; Lazar AJ; Hunt KK; Anderson ML; Creighton CJ; Lev D; Pollock RE
    Ann Surg Oncol; 2013 Jul; 20(7):2364-72. PubMed ID: 23334251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis of clinicopathology and prognosis in 181 patients with gastrointestinal stromal tumors].
    Zhang Y; Cao H; Wang M; Shen DP; Shen ZY; Ni XZ; Wu ZY; Shen YY; Liu Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):150-4. PubMed ID: 19296250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
    Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
    Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
    Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
    J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential.
    Ozgüç H; Yilmazlar T; Yerci O; Soylu R; Tümay V; Filiz G; Zorluoglu A
    J Gastrointest Surg; 2005 Mar; 9(3):418-29. PubMed ID: 15749606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Expression of DOG-1 in gastrointestinal stromal tumors and its significance].
    Peng Z; Wu K; Tong Q; Wang GB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):256-9. PubMed ID: 23536347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.